RMTG Q1 sales up 67% to $1.35M; achieves operating profit of $134K

Regenerative Medical Technology Group Inc.

2025-Q1 EPS reported -$0.06 revenue$1,364,341

Q1 2025 revenue $1.35M, a 67% increase over Q1 2024.
Operating profit of $134,000 for the quarter; positive cash flow noted.
New Turnkey membership revenue stream: clinics pay upfront fee and exclusive purchasing.
RMTG plans one new member per quarter initially, accelerating next year.
CEO expects continued revenue growth and sustained operating income; formal guidance forthcoming.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.